Crescent Grove Advisors LLC reduced its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,961 shares of the pharmacy operator’s stock after selling 499 shares during the quarter. Crescent Grove Advisors LLC’s holdings in CVS Health were worth $268,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the 3rd quarter valued at about $25,000. Ridgewood Investments LLC raised its holdings in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health in the third quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health during the 3rd quarter valued at $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a report on Tuesday, December 3rd. Finally, StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $68.71.
CVS Health Stock Performance
NYSE CVS opened at $54.71 on Monday. The company has a market cap of $68.84 billion, a P/E ratio of 13.88, a P/E/G ratio of 0.80 and a beta of 0.59. The business’s 50 day moving average price is $51.24 and its 200-day moving average price is $56.21. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the business earned $2.21 EPS. The business’s revenue was up 6.3% on a year-over-year basis. Sell-side analysts predict that CVS Health Co. will post 5.22 earnings per share for the current year.
CVS Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.86%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MP Materials: Rare Earth Elements Powering the EV Boom
- Stock Analyst Ratings and Canadian Analyst Ratings
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.